Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome

被引:0
作者
Christophe Guervilly
Magali Bisbal
Jean Marie Forel
Malika Mechati
Samuel Lehingue
Jeremy Bourenne
Gilles Perrin
Romain Rambaud
Melanie Adda
Sami Hraiech
Elisa Marchi
Antoine Roch
Marc Gainnier
Laurent Papazian
机构
[1] Hôpital Nord,Réanimation des Détresses Respiratoires et Infections Sévères
[2] Aix-Marseille Univ,Département d’anesthésie et de Réanimation, Réanimation Polyvalente
[3] Assistance Publique-Hôpitaux de Marseille,Réanimation des Urgences et Medicale
[4] URMITE UMR CNRS 7278,undefined
[5] Institut Paoli-Calmettes,undefined
[6] CHU la Timone 2 Marseille,undefined
[7] Aix-Marseille Université,undefined
[8] Assistance Publique-Hôpitaux de Marseille,undefined
[9] Hôpital Nord,undefined
[10] Service d’Accueil des Urgence,undefined
来源
Intensive Care Medicine | 2017年 / 43卷
关键词
Acute respiratory distress syndrome; Neuromuscular blocking agent; Esophageal pressure; Transpulmonary pressure; Driving pressure;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:408 / 418
页数:10
相关论文
共 86 条
[1]  
Briel M(2000)Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 342 1301-1308
[2]  
Meade M(2010)Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis JAMA 303 865-873
[3]  
Mercat A(2013)Prone positioning in severe acute respiratory distress syndrome N Engl J Med 368 2159-2168
[4]  
Guérin C(2012)Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial Lancet 379 229-235
[5]  
Reignier J(2014)Simvastatin in the acute respiratory distress syndrome N Engl J Med 371 1695-1703
[6]  
Richard JC(2014)Rosuvastatin for sepsis-associated acute respiratory distress syndrome N Engl J Med 370 2191-2200
[7]  
Gao Smith F(2014)Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial PLoS One 14 e90983-568
[8]  
Perkins GD(2011)Randomized, placebo-controlled clinical trial of an aerosolized β Am J Respir Crit Care Med 184 561-1185
[9]  
Gates S(2010)-agonist for treatment of acute lung injury Cochrane Database Syst Rev 7 CD002787-1116
[10]  
McAuley DF(2014)Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults Respir Care 59 1178-1180